Evolving pneumococcal epidemiology and vaccine impact in the Netherlands, 2004–2024: Carriage and invasive disease
Open Access
- 16 November 2025
- journal article
- Published by Elsevier in Journal of Infection
- Vol. 91 (6) , 106658
Abstract
No abstract availableKeywords
Funding Information
- Rijksinstituut voor Volksgezondheid en Milieu
- Ministerie van Volksgezondheid, Welzijn en Sport
This publication has 31 references indexed in Scilit:
- The COVID-19 pandemic as an opportunity for unravelling the causative association between respiratory viruses and pneumococcus-associated disease in young children: a prospective studyEBioMedicine, 2023
- Association of Nonpharmaceutical Interventions During the COVID-19 Pandemic With Invasive Pneumococcal Disease, Pneumococcal Carriage, and Respiratory Viral Infections Among Children in FranceJAMA Network Open, 2022
- Effectiveness of 10 and 13-valent pneumococcal conjugate vaccines against invasive pneumococcal disease in European children: SpIDnet observational multicentre studyVaccine, 2022
- Clinical and Economic Burden of Pneumococcal Disease Due to Serotypes Contained in Current and Investigational Pneumococcal Conjugate Vaccines in Children Under Five Years of AgeInfectious Diseases and Therapy, 2021
- In-depth analysis of pneumococcal serotypes in Belgian children (2015–2018): Diversity, invasive disease potential, and antimicrobial susceptibility in carriage and diseaseVaccine, 2021
- The relative invasive disease potential of Streptococcus pneumoniae among children after PCV introduction: A systematic review and meta-analysisJournal of Infection, 2018
- Invasive pneumococcal disease: Clinical outcomes and patient characteristics 2–6 years after introduction of 7-valent pneumococcal conjugate vaccine compared to the pre-vaccine period, the NetherlandsVaccine, 2016
- Nasopharyngeal carriage of Streptococcus pneumoniae and other bacteria in the 7th year after implementation of the pneumococcal conjugate vaccine in the NetherlandsVaccine, 2016
- Serotype specific invasive capacity and persistent reduction in invasive pneumococcal diseaseVaccine, 2010
- Effect of Reduced-Dose Schedules With 7-Valent Pneumococcal Conjugate Vaccine on Nasopharyngeal Pneumococcal Carriage in ChildrenJAMA, 2009